Although, germline polymorphic mutations/SNPs in POLG1 have been shown to result in decreased mtDNA content, decreased OXPHOS and several human mitochondrial diseases, their role in the pathogenesis of cancer is still unclear [7,8,15–18,23,24]. This evidence concerns the gene POLG and mitochondrial disease.